skip to Main Content

LED Medical Diagnostics Announces Further Updates to Board

  • September 06, 2014
  • News Releases

BURNABY, British Columbia – September 5, 2014 – LED Medical Diagnostics Inc. (“LED Medical” or “the Company”) wishes to further update its announcement of September 2, 2014 regarding the new board of directors of LED Medical following the Annual General Meeting held on August 28, 2014. LED Medical and Al Fiore, the Chairman and CEO of PowerWorks, a leading provider of high end electrical contracting services, have subsequently determined that Mr. Fiore will serve LED Medical in an advisory role instead of a directorship role.

“Al will offer LED Medical invaluable assistance and operational support as a result of his extensive experience in the dental market, including his previous experience as Senior Vice President of Corporate Development and Marketing for PracticeWorks Inc., one of the largest technology companies in the oral healthcare sector prior to its acquisition by The Eastman Kodak Company,” stated Dr. David Gane, CEO of LED Medical.

As a result, the board of directors of LED Medical consists of Darryl J. Yea (Chair), Dr. Gane, Rick Pauls, Lamar Roberts, Rodger Tourigny and Praveen Varshney.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc. is a leading developer of LED-based visualization technologies for the medical industry. The Company is currently listed on the Toronto Stock Exchange (TSX-V) under the symbol “LMD”, the OTCQX under the symbol “LEDIF”, as well as the Frankfurt Stock Exchange under the symbol “LME”. For more information, visit

LED Dental Inc., a wholly-owned subsidiary, is backed by an experienced leadership team dedicated to a higher level of service and support. LED Dental offers advanced diagnostic imaging equipment that seamlessly integrates into dental practices. The Company is committed to providing dental practitioners with the best technology available by identifying and adding strong products to its growing portfolio. Additionally, the company manufactures the award-winning VELscope® Vx Enhanced Oral Assessment System, the first system in the world to apply tissue fluorescence visualization technology to the oral cavity. The VELscope® Vx is now used to conduct more screenings for oral cancer and other oral mucosal diseases than any other adjunctive device. For more information, call 888.541.4614 or visit